Chain Drug Review - Marketing of Lilly’s Evista investigated
Monday, December 22nd, 2008 WASHINGTON — The United States Department of Justice is investigating the way Eli Lilly and Co. is marketing its drug Evista.
The criminal inquiry, which is being conducted by the Justice Department’s Office of Consumer Litigation in cooperation with the U.S. attorney’s office in Indianapolis, is investigating whether Lilly improperly promoted Evista for the prevention of breast cancer.
While gro…
